10x Genomics Bruttó árrés
Mi az 10x Genomics Bruttó árrés?
A Bruttó árrés az 10x Genomics, Inc. - 66.15%
Mi a Bruttó árrés meghatározása?
A bruttó árrés az árbevétel és az eladott áruk költségének különbsége, osztva bevételekkel, és százalékban kifejezve.
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
Bruttó árrés a Health Care szektor a NASDAQ-on cégekben a 10x Genomics -hoz képest
Mit csinál 10x Genomics?
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
bruttó árrés -hoz hasonló cégek 10x Genomics
- Shilpa Medicare nak Bruttó árrés 66.08% van
- Vocera Communication Inc nak Bruttó árrés 66.08% van
- SPS Commerce nak Bruttó árrés 66.09% van
- First Property plc nak Bruttó árrés 66.13% van
- Solutions 30 SE nak Bruttó árrés 66.14% van
- Australian Ethical Investment Ltd nak Bruttó árrés 66.14% van
- 10x Genomics nak Bruttó árrés 66.15% van
- Western Areas nak Bruttó árrés 66.16% van
- RPG Life Sciences nak Bruttó árrés 66.17% van
- Chugai Pharmaceutical Co nak Bruttó árrés 66.18% van
- Presidio Property Trust nak Bruttó árrés 66.19% van
- Dragontail Systems nak Bruttó árrés 66.21% van
- Wishpond Technologies nak Bruttó árrés 66.21% van